OSGEPL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.243050E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.477600E-02
Normal-vs-Stage2
1.864740E-03
Normal-vs-Stage3
4.013600E-02
Normal-vs-Stage4
1.283560E-01
Stage1-vs-Stage2
3.968200E-01
Stage1-vs-Stage3
5.627600E-02
Stage1-vs-Stage4
8.066400E-01
Stage2-vs-Stage3
1.029780E-01
Stage2-vs-Stage4
6.422400E-01
Stage3-vs-Stage4
1.250580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.879730E-03
Normal-vs-AfricanAmerican
2.721700E-02
Normal-vs-Asian
1.300480E-02
Caucasian-vs-AfricanAmerican
4.773400E-01
Caucasian-vs-Asian
3.707600E-01
AfricanAmerican-vs-Asian
9.752400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.847800E-04
Normal-vs-Female
5.984400E-03
Male-vs-Female
3.873600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.269050E-01
Normal-vs-Age(41-60Yrs)
6.122200E-03
Normal-vs-Age(61-80Yrs)
1.062880E-03
Normal-vs-Age(81-100Yrs)
2.476200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.616200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.271200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.249800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.041200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.457000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.387600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.969900E-02
Normal-vs-Daily Drinker
1.102300E-03
Normal-vs-Weekly Drinker
2.402000E-02
Normal-vs-Occasional Drinker
2.024600E-01
Normal-vs-Social Drinker
6.262100E-02
Non Drinker-vs-Daily Drinker
5.918000E-01
Non Drinker-vs-Weekly Drinker
7.618000E-01
Non Drinker-vs-Occasional Drinker
6.477200E-01
Non Drinker-vs-Social Drinker
2.077400E-01
Daily Drinker-vs-Weekly Drinker
3.766000E-01
Daily Drinker-vs-Occasional Drinker
2.359600E-01
Daily Drinker-vs-Social Drinker
4.208200E-02
Weekly Drinker-vs-Occasional Drinker
9.690000E-01
Weekly Drinker-vs-Social Drinker
3.503400E-01
Occasional Drinker-vs-Social Drinker
2.481800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.798600E-01
Normal-vs-Grade 2
7.490400E-01
Normal-vs-Grade 3
2.055200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.909200E-01
Grade 1-vs-Grade 3
8.455600E-02
Grade 1-vs-Grade 4
7.798600E-01
Grade 2-vs-Grade 3
8.264300E-02
Grade 2-vs-Grade 4
7.490400E-01
Grade 3-vs-Grade 4
2.055200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.440800E-03
Normal-vs-NonDiabetic
5.373700E-04
Diabetic-vs-NonDiabetic
9.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.646500E-02
Normal-vs-NoPancreatitis
5.776300E-04
Pancreatitis-vs-NoPancreatitis
6.988400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.663500E-03
Normal-vs-N1
1.636920E-03
N0-vs-N1
6.129600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.624600E-01
Normal-vs-TP53-NonMutant
3.505200E-01
TP53-Mutant-vs-TP53-NonMutant
8.154600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
